Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer

Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent paper by Alejandro Ríos-Hoyo et al., titled “Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer” published on Journal of Clinical Oncology.

Authors: Alejandro Ríos-Hoyo, Erin Cobain, Laura A. Huppert, Peter D. Beitsch, Thomas A. Buchholz, Laura Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Lajos Pusztai.

“Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer
– Congratulations to Alejandro Ríos-Hoyo.”

Source: Sergio Cifuentes Canaval/LinkedIn